← brief for 2026-08-10 · Slowing decline

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Trial No results yet Not peer reviewed

Key takeaways

This study looks at "physiologic insulin resensitization," a way of giving insulin, in people with chronic kidney disease and type 2 diabetes. Researchers want to see how it affects their health. Few details are given, and it is just starting, so there are no results yet.

Who did this work

Run by Well Cell Global. Sungchun Lee, MD (Arizona Kidney Disease and Hypertension Centers)
Sites: Arizona Kidney Disease and Hypertension Center · Innovative Diabetic Center

Source

Trial registration · ClinicalTrials.gov — CKD recruiting · 2026-08-04
https://clinicaltrials.gov/study/NCT07187479